Akeso, Inc. (9926.HK)
| Previous Close | 32.000 |
| Open | 36.800 |
| Bid | 43.900 x N/A |
| Ask | 44.000 x N/A |
| Day's Range | 36.800 - 60.000 |
| 52 Week Range | 26.450 - 60.000 |
| Volume | |
| Avg. Volume | 9,052,400 |
| Market Cap | 38.098B |
| Beta (5Y Monthly) | 0.48 |
| PE Ratio (TTM) | 16.60 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Insider Monkey
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript May 1, 2024 Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06. SMMT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies […]
- Insider Monkey
Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2023 Earnings Call Transcript
Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2023 Earnings Call Transcript February 20, 2024 Summit Therapeutics Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to Summit’s Fourth Quarter and Year End 2023 Earnings Call. [Operator Instructions] Please […]
- Thomson Reuters StreetEvents
Q2 2023 Summit Therapeutics Inc Earnings Call
Q2 2023 Summit Therapeutics Inc Earnings Call
